A BioSpace analysis of all 80 priority review vouchers that have been handed out across the three FDA programs that offer ...

The FDA has accepted for Priority Review the BLA for PRGN-2012 for the treatment of adults with recurrent respiratory papillomatosis.

Chimerix’s lead clinical pipeline candidate is dordaviprone, a first-in-class small molecule treatment designed to selectively target the mitochondrial protease ClpP and dopamine receptor D2 (DRD2).

A drugmaker developing a brain tumor treatment is being acquired in a $935 million deal.

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...

The acquisition is expected to enhance Jazz's oncology portfolio by adding dordaviprone, a novel small molecule therapy in ...

The stock makes the NASDAQ top percentage gainers list on acquisition news today, currently trading at $8.44, up 3.48, ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") and Chimerix (Nasdaq: CMRX) ("Chimerix"), today announced the companies have entered into a definitive agreement for Jazz to acquire ...

From 2019-2023, North Carolina increased the number of life sciences business establishments by 43%. To learn more in the ...

In their heedless quest to chainsaw the federal budget, the world’s most powerful person and the richest man on earth managed ...

Audited results confirm full-year revenue of DKK 5,716 million and EBITDA of DKK 1,603 million.Two new early-stage pipeline programs, Lyme disease and Epstein-Barr Virus (EBV), introduced. COPENHAGEN ...

Two Foreign Corrupt Practices Act cases—one in Pennsylvania and one in Florida—could get dropped depending on the outcome of the Justice Department’s ongoing review of FCPA enforcement matters.